---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-014527"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T17:18:29.078521+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics Q1 2025 revenue $3.4M, net loss $2.9M; partnerships expand distribution

## Summary
- Revenue of $3.4M down 11% YoY ($3.8M); net loss $2.9M ($0.12/sh) vs $3.4M ($0.20/sh) in Q1 2024.
- Gross margin improved to 53.5% from 51.9%; cash used in operations fell 43% to $2.0M.
- Named National Seating & Mobility as exclusive U.S. CRT distributor for Ekso Indego Personal.
- Appointed Bionic Prosthetics & Orthotics Group as first O&P distributor for Ekso Indego Personal.
- Cash and restricted cash $8.1M at March 31, 2025; $3.8M net proceeds from warrant exercises.

## SEC filing metadata
- accession: 0001437749-25-014527
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000143774925014527/0001437749-25-014527-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000143774925014527/ekso20250318c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-014527
- JSON: https://secwatch.observer/filing/0001437749-25-014527.json
- Plain text: https://secwatch.observer/filing/0001437749-25-014527.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.